ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007

In Brief: Coalition Dinner Celebrates NCI’s 50th Anniversary, Honors Lasker, Three Ex-Senators

September 18, 1987

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998